The most convincing evidence for the concept of oncogene addiction comes from the examples of therapeutic efficacy of antibodies or drugs that target specific oncogenes in human cancers such as the antibody trastuzumab (Herceptin), which targets the receptor tyrosine kinase HER-2/NEU in breast cancer. Here, ERBB2 is linked to breast carcinoma.